BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11272901)

  • 21. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Abbott JJ; Erickson-Johnson M; Wang X; Nascimento AG; Oliveira AM
    Mod Pathol; 2006 Nov; 19(11):1512-8. PubMed ID: 16980946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.
    Salgado R; Llombart B; M Pujol R; Fernández-Serra A; Sanmartín O; Toll A; Rubio L; Segura S; Barranco C; Serra-Guillén C; Yébenes M; Salido M; Traves V; Monteagudo C; Sáez E; Hernández T; de Álava E; Llombart-Bosch A; Solé F; Guillén C; Espinet B; López-Guerrero JA
    Genes Chromosomes Cancer; 2011 Jul; 50(7):510-7. PubMed ID: 21484928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.
    O'Brien KP; Seroussi E; Dal Cin P; Sciot R; Mandahl N; Fletcher JA; Turc-Carel C; Dumanski JP
    Genes Chromosomes Cancer; 1998 Oct; 23(2):187-93. PubMed ID: 9739023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
    Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid and efficient newly established method to detect COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans.
    Yokoyama Y; Shimizu A; Okada E; Ishikawa O; Motegi S
    Biochem Biophys Res Commun; 2012 Aug; 425(2):353-6. PubMed ID: 22842571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.
    Lu Y; Li T; Chen M; Peng H; Du T; Qiu Y; Zhang H
    Virchows Arch; 2022 Aug; 481(2):313-319. PubMed ID: 35171326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDGFB quantification is a useful tool in the diagnosis of dermatofibrosarcoma protuberans: a study of 10 cases.
    Muchemwa FC; Wakasugi S; Honda Y; Ihn H
    Clin Exp Dermatol; 2010 Apr; 35(3):295-9. PubMed ID: 19663837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatofibrosarcoma protuberans with COL1A1 (exon 18) -PDGFB (exon 2) fusion transcript.
    Saeki H; Ohmatsu H; Hoashi T; Asano N; Idezuki T; Kawabata Y; Asahina A; Kikuchi K; Tamaki K
    Br J Dermatol; 2003 May; 148(5):1028-31. PubMed ID: 12786837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
    Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
    Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
    Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
    Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudocystic dermatofibrosarcoma protuberans: report of two cases and demonstration of COL1A1-PDGFB rearrangement.
    Shvartsbeyn M; Lazar AJ; Lopez-Terrada D; Meehan SA
    J Cutan Pathol; 2012 Mar; 39(3):356-60. PubMed ID: 22335595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.
    Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL
    Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans.
    Nakanishi G; Shirai M; Kato T; Fujii N; Fujimoto N; Tanaka T; Shirafuji Y; Suzuki N; Otsuka M; Asagoe K; Iwatsuki K; Tanaka R; Fujimoto W; Hanawa F; Shimada S; Nakagawa Y; Tanioka M
    Eur J Dermatol; 2010; 20(4):528-9. PubMed ID: 20406730
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.
    Segura S; Salgado R; Toll A; Martín-Ezquerra G; Yébenes M; Sáez A; Solé F; Barranco C; Umbert P; Espinet B; Pujol RM
    Hum Pathol; 2011 Feb; 42(2):176-84. PubMed ID: 21111450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.
    Jahanseir K; Xing D; Greipp PT; Sukov WR; Keeney GL; Howitt BE; Schoolmeester JK
    Int J Gynecol Pathol; 2018 Nov; 37(6):537-546. PubMed ID: 29140881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.
    Maire G; Fraitag S; Galmiche L; Keslair F; Ebran N; Terrier-Lacombe MJ; de Prost Y; Pedeutour F
    Arch Dermatol; 2007 Feb; 143(2):203-10. PubMed ID: 17310000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
    Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
    Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.